LONDON, July 2 (Reuters) - GlaxoSmithKline Plc:
* GSK concludes settlement with US govern
ment
* Final settlement of $3 billion covered by existing legal provisions announced in November 2011
* Fundamental changes to US compliance, marketing and selling procedures
implemented in recent years
* Will make payments totalling $3 billion which are covered by existing provisions, funded through existing cash resources
* The after tax cost will be approximately $150M lower than provided
* A credit will be recorded to the non-core tax charge for the second quarter
2012
* Net effect of these movements on total earnings is expected to be neutral
For more information, please click on
((London Equities Newsroom; +44 20 7542 7717))
(For more news, please click here)
COPYRIGHT
Copyright Thomson Reuters 2012. All rights reserved.
The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.